More on Reforming the FDA

Two Democratic senators introduce bills intended to reform the FDA:

• Sen. Edward Kennedy (D-MA) introduces the Affordable Health Care Act, S. 16. This would authorize HHS to require drug sponsors to conduct Phase IV studies which would monitor the safety of drugs that are already on the market (ex: vioxx).
• Sen. Christopher Dodd (D-CN), introduced the Patient Protection Act of 2005, to establish a new Office of Patient Protection which would report directly to the FDA commissioner.

Meanwhile, the FDA has released a current CBER organizational chart for the Center for Biologics Evaluation and Research.